Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.21.1
Restatement of Previously Issued Financial Statements (Tables)
9 Months Ended
Sep. 30, 2020
Accounting Changes and Error Corrections [Abstract]  
Summary of Reconciliation of the Consolidated Balance Sheets, Consolidated Statements of Operations and Consolidated Cash Flows from the Prior Periods to the Restated Amounts

The following presents a reconciliation of the Balance Sheets, Statements of Operations, and Statements of Cash Flows from the prior periods as previously reported to the restated amounts as of September 30, 2020 and December 31, 2019. The Statements of Shareholders’ Equity for the three and nine month period ended September 30, 2020 and 2019 have been restated respectively, for the restatement impact to net (loss) income and common stock subject to possible redemption. See the Statement of Operations reconciliation tables below for additional information on the restatement and impact to net (loss) income.

 

     September 30, 2020  
     As Reported      Restatement
Adjustments
    As Restated  

Assets:

       

Current assets:

       

Cash

   $ 974,317    $ —       $ 974,317

Prepaid expenses

     47,084      —         47,084
  

 

 

    

 

 

   

 

 

 

Total current assets

     1,021,401      —         1,021,401

Investments held in Trust Account

     293,255,540      —         293,255,540
  

 

 

    

 

 

   

 

 

 

Total assets

   $ 294,276,941    $ —       $ 294,276,941
  

 

 

    

 

 

   

 

 

 

Liabilities and Shareholders’ Equity:

       

Current liabilities:

       

Accounts payable

   $ 371,225    $ —       $ 371,225

Accrued expenses

     414,571      —         414,571
  

 

 

    

 

 

   

 

 

 

Total current liabilities

     785,796      —         785,796

Warrant liability

     —          21,096,250 (a)      21,096,250

Deferred underwriting commissions

     9,187,500      —         9,187,500
  

 

 

    

 

 

   

 

 

 

Total liabilities

     9,973,296      21,096,250       31,069,546
  

 

 

    

 

 

   

 

 

 

Commitments and contingencies

       

Ordinary shares, $0.0001 par value; 28,750,000 shares subject to possible redemption at $10.00 per share at September 30, 2020

     279,303,640      8,196,360 (a)      287,500,000

Shareholders’ Equity:

       

Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding

     —          —         —    

Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 7,187,500 shares issued and outstanding (excluding 28,750,000 shares subject to possible redemption) at September 30, 2020

     801      (82 )(a)      719

Additional paid-in capital

     895,230      (895,230 )(a)      —    

Retained earnings / (Accumulated deficit)

     4,103,974      (28,397,298 )(a)      (24,293,324
  

 

 

    

 

 

   

 

 

 

Total shareholders’ equity

     5,000,005      (29,292,610     (24,292,605
  

 

 

    

 

 

   

 

 

 

Total Liabilities and Shareholders’ Equity

   $ 294,276,941    $ —       $ 294,276,941
  

 

 

    

 

 

   

 

 

 

 

     December 31, 2019  
     As Reported      Restatement
Adjustments
    As Restated  

Assets:

       

Current assets:

       

Cash

   $ 1,589,795    $ —       $ 1,589,795

Prepaid expenses

     62,738      —         62,738
  

 

 

    

 

 

   

 

 

 

Total current assets

     1,652,533      —         1,652,533

Investments held in Trust Account

     292,054,158      —         292,054,158
  

 

 

    

 

 

   

 

 

 

Total assets

   $ 293,706,691    $ —       $ 293,706,691
  

 

 

    

 

 

   

 

 

 

Liabilities and Shareholders’ Equity:

       

Current liabilities:

       

Accounts payable

   $ 86,595    $ —       $ 86,595

Accrued expenses

     8,860      —         8,860
  

 

 

    

 

 

   

 

 

 

Total current liabilities

     95,455      —         95,455

Warrant liability

     —          18,817,500 (a)      18,817,500

Deferred underwriting commissions

     9,187,500      —         9,187,500
  

 

 

    

 

 

   

 

 

 

Total liabilities

     9,282,955      18,817,500       28,100,455
  

 

 

    

 

 

   

 

 

 

Commitments and contingencies

       

Ordinary shares, $0.0001 par value; 28,750,000 shares subject to possible redemption at $10.00 per share at December 31, 2019

     279,423,730      8,076,270 (a)      287,500,000

Shareholders’ Equity:

       

Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding

     —          —         —    

Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 7,187,500 shares issued and outstanding (excluding 28,750,000 and shares subject to possible redemption) at December 31, 2019

     800      (81 )(a)      719

Additional paid-in capital

     775,141      (775,141 )(a)      —    

Retained earnings / (Accumulated deficit)

     4,224,065      (26,118,548 )(a)      (21,894,483
  

 

 

    

 

 

   

 

 

 

Total shareholders’ equity

     5,000,006      (26,893,770     (21,893,764
  

 

 

    

 

 

   

 

 

 

Total Liabilities and Shareholders’ Equity

   $ 293,706,691    $ —       $ 293,706,691
  

 

 

    

 

 

   

 

 

 

 

The following tables contain the restatement of previously reported unaudited Statements of Operations for the three and nine month periods ended September 30, 2020 and 2019.

 

     For the three months ended September 30, 2020  
     As Reported     Restatement
Adjustments
    As Restated  

General and administrative expenses

   $ 1,058,292   $ —       $ 1,058,292
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (1,058,292     —         (1,058,292

Loss on revaluation of warrant liability

     —         (1,106,250 )(a)      (1,106,250

Loss on marketable securities, dividends and interest held in Trust Account

     86,803     —         86,803
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (971,489   $ (1,106,250   $ (2,077,739
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Public Shares

     28,750,000     —         28,750,000
  

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share, Public Shares

   $ —       $ (0.06 )(a)    $ (0.06
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Founder Shares

     7,187,500     —         7,187,500
  

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share, Founder Shares

   $ (0.15   $ 0.09 (a)    $ (0.06
  

 

 

   

 

 

   

 

 

 

 

     For the three months ended September 30, 2019  
     As Reported     Restatement
Adjustments
    As Restated  

General and administrative expenses

   $ 111,750   $ —       $ 111,750
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (111,750     —         (111,750

Issuance costs allocated to the public warrants

     —         —         —    

Loss on revaluation of warrant liability

     —         (951,250 )(a)      (951,250

Gain on marketable securities, dividends and interest held in Trust Account

     1,561,854     —         1,561,854
  

 

 

   

 

 

   

 

 

 

Net income

   $ 1,450,104   $ (951,250   $ 498,854
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Public Shares

     28,750,000     —         28,750,000
  

 

 

   

 

 

   

 

 

 

Basic and diluted net income (loss) per share, Public Shares

   $ 0.05   $ (0.03 )(a)    $ 0.02  
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Founder Shares

     7,187,500     —         7,187,500
  

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share, Founder Shares

   $ (0.02   $ (0.01 )(a)    $ (0.03
  

 

 

   

 

 

   

 

 

 

 

     For the nine months ended September 30, 2020  
     As Reported     Restatement
Adjustments
    As Restated  

General and administrative expenses

   $ 1,321,473   $ —       $ 1,321,473
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (1,321,473     —         (1,321,473

Loss on revaluation of warrant liability

     —         (2,278,750 )(a)      (2,278,750

Gain on marketable securities, dividends and interest held in Trust Account

     1,201,382     —         1,201,382
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (120,091   $ (2,278,750   $ (2,398,841
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Public Shares

     28,750,000     —         28,750,000
  

 

 

   

 

 

   

 

 

 

Basic and diluted net income (loss) per share, Public Shares

   $ 0.04   $ (0.10 )(a)    $ (0.06
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Founder Shares

     7,187,500     —         7,187,500
  

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share, Founder Shares

   $ (0.18   $ 0.08 (a)    $ (0.10
  

 

 

   

 

 

   

 

 

 
     For the nine months ended September 30, 2019  
     As Reported     Restatement
Adjustments
    As Restated  

General and administrative expenses

   $ 245,980   $ —       $ 245,980
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (245,980     —         (245,980

Issuance costs allocated to the public warrants

     —         (648,239 )(a)      (648,239

Gain on revaluation of warrant liability

     —         2,666,250 (a)      2,666,250

Gain on marketable securities, dividends and interest held in Trust Account

     3,322,448     —         3,322,448
  

 

 

   

 

 

   

 

 

 

Net income

   $ 3,076,468   $ 2,018,011     $ 5,094,479
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Public Shares

     28,750,000     —         28,750,000
  

 

 

   

 

 

   

 

 

 

Basic and diluted net income per share, Public Shares

   $ 0.12   $ 0.23 (a)    $ 0.35  
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average shares outstanding of Founder Shares

     7,187,500     —         7,187,500
  

 

 

   

 

 

   

 

 

 

Basic and diluted net loss per share, Founder Shares

   $ (0.03   $ (0.67 )(a)    $ (0.70
  

 

 

   

 

 

   

 

 

 

 

The following tables contain the restatement of previously reported unaudited Statements of Cash Flows for the three and nine month periods ended September 30, 2020 and 2019.

 

     For the nine months ended September 30, 2020  
     As Reported     Restatement
Adjustments
    As Restated  

Cash Flows from Operating Activities:

      

Net loss

   $ (120,091   $ (2,278,750 )(a)    $ (2,398,841

Adjustments to reconcile net loss to net cash used in operating activities:

      

Gain on marketable securities, dividends and interest held in Trust Account

     (1,201,382     —         (1,201,382

Loss on revaluation of warrant liability

     —         2,278,750 (a)      2,278,750

Changes in operating assets and liabilities:

      

Prepaid expenses

     15,654     —         15,654

Accounts payable

     284,630     —         284,630

Accrued expenses

     405,711     —         405,711
  

 

 

   

 

 

   

 

 

 

Net cash used in operating activities

     (615,478     —         (615,478
  

 

 

   

 

 

   

 

 

 

Net change in cash

     (615,478     —         (615,478

Cash - beginning of period

     1,589,795     —         1,589,795
  

 

 

   

 

 

   

 

 

 

Cash - end of period

   $ 974,317   $ —       $ 974,317
  

 

 

   

 

 

   

 

 

 

Supplemental disclosure of noncash activities:

      

Remeasurement of ordinary shares subject to possible redemption

   $ (120,090   $ 120,090 (a)    $ —  

 

     For the nine months ended September 30, 2019  
     As Reported     Restatement
Adjustments
    As Restated  

Cash Flows from Operating Activities:

      

Net income

   $ 3,076,468   $ 2,018,011 (a)    $ 5,094,479

Adjustments to reconcile net income to net cash used in operating activities:

 

General and administrative expenses paid by related party

     2,206     —         2,206

Gain on marketable securities, dividends and interest held in Trust Account

     (3,322,448     —         (3,322,448

Gain on revaluation of warrant liability

     —         (2,666,250 )(a)      (2,666,250

Changes in operating assets and liabilities:

      

Prepaid expenses

     (101,988     —         (101,988

Accounts payable

     79,620       —         79,620  

Accrued expenses

     (87,694     —         (87,694
  

 

 

   

 

 

   

 

 

 

Net cash used in operating activities

     (353,836     (648,239     (1,002,075
  

 

 

   

 

 

   

 

 

 

Cash Flows from Investing Activities:

      

Cash deposited in Trust Account

     (287,500,000     —         (287,500,000
  

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (287,500,000     —         (287,500,000
  

 

 

   

 

 

   

 

 

 

Cash Flows from Financing Activities:

      

Proceeds from note payable to related party

     250,000     —         250,000

Repayment of note payable and advances from related party

     (252,206     —         (252,206

Proceeds received from initial public offering

     287,500,000     —         287,500,000

Proceeds from private placement

     7,750,000     —         7,750,000

Offering costs paid

     (5,800,229     648,239 (a)      (5,151,990
  

 

 

   

 

 

   

 

 

 

Net cash provided by financing activities

     289,447,565     648,239       290,095,804
  

 

 

   

 

 

   

 

 

 

Net change in cash

     1,593,729     —         1,593,729

Cash - beginning of period

     25,000     —         25,000
  

 

 

   

 

 

   

 

 

 

Cash - end of period

   $ 1,618,729   $ —       $ 1,618,729
  

 

 

   

 

 

   

 

 

 

Supplemental disclosure of noncash activities:

      

Offering costs included in accrued expenses

   $ 85,000   $ —       $ 85,000

Offering costs included in accounts payable

   $ 2,600   $ —       $ 2,600

Remeasurement of ordinary shares subject to possible redemption

   $ 278,273,440   $ (251,483,850 )(a)    $ 26,789,590

Deferred underwritting commissions

   $ —       $  9,187,500  (a)    $ 9,187,500  

 

(a)

The Restatement Adjustments reflect the entries to record the initial liability for the Public and Private Warrants issued as part of Replay’s initial public offering and private placement, respectively, and to account for the adjustment to fair value of this liability at the end of each period presented. The initial fair value of the Public and Private Warrants of $19.3 million was recorded in April 2019 as a warrant liability with an offset to additional paid-in capital. In addition, the initial adjusting entry was also to expense approximately $648 thousand of costs directly associated with the issuance of the Public Warrants. The proceeds received from the sale of private warrants in excess of their fair value of $775 thousand was recognized as additional paid-in capital. For each subsequent quarter end, starting with June 30, 2019, the liability was revalued and the change in fair value reflected in “Gain/loss on revaluation of warrant liability” in the Statements of Operations. The Restatement Adjustment also reflect the impact of the remeasurement as of June 30, 2019 of the redeemable shares classified in temporary equity to align with the expected redemption amount of $287.5 million, the impact of the remeasurement of approximately $26.8 million was recognized as increase to the temporary equity balance with the offset to additional paid in capital and accumulated deficit. Additionally, the redemption amount was increased by the gains on marketable securities, dividends and interest held in the trust account, which is also subject to redemption by the ordinary shareholders. Lastly, the earning per share for both the Public and Founder shares was adjusted to account for the measurement adjustment to the temporary equity in accordance with the two classes of shares method and the guidance in ASC 480-10-S99-3A.